Welcome to our dedicated page for TD SYNNEX CORPORATION SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vendor concentration, acquisition costs, and supply-chain swings make TD SYNNEX’s regulatory disclosures far from light reading. If you have ever opened a 10-K hoping to isolate cloud revenue or searched dozens of Form 4s for executive stock moves, you know the challenge of decoding this solutions aggregator’s complex numbers.
Stock Titan solves that problem. Our AI-powered summaries turn a 250-page TD SYNNEX annual report 10-K simplified into key takeaways, while real-time alerts surface every TD SYNNEX Form 4 insider transactions real-time. Want the next TD SYNNEX quarterly earnings report 10-Q filing? We post it seconds after EDGAR, then highlight inventory days, gross-margin shifts, and regional sales trends. Need a quick view of material developments? The platform tags each TD SYNNEX 8-K material events explained so you see the impact of new vendor agreements instantly. Even the TD SYNNEX proxy statement executive compensation is distilled, outlining option grants and performance metrics in plain English.
Use the page to:
- Track TD SYNNEX insider trading Form 4 transactions alongside AI-flagged buying patterns
- Compare segments through TD SYNNEX earnings report filing analysis
- Get context for capital raises with TD SYNNEX 8-K material events explained
Whether you are understanding TD SYNNEX SEC documents with AI for strategic planning or monitoring a sudden uptick in TD SYNNEX executive stock transactions Form 4, Stock Titan delivers every form�10-K, 10-Q, 8-K, Form 4, S-8, 424B, and more—complete, searchable, and always current. TD SYNNEX SEC filings explained simply means you spend less time scrolling and more time deciding.
TD SYNNEX Corporation Director Richard Hume has filed a Form 144, indicating a proposed sale of 63,310 shares of common stock with an aggregate market value of $8,624,499.72. The transaction is planned to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of June 27, 2025.
The securities were acquired through a stock option exercise on June 27, 2025, with payment made in cash. The filing indicates that Hume has not sold any other securities of the issuer during the past 3 months. With TD SYNNEX having 83,921,412 shares outstanding, this proposed sale represents approximately 0.075% of total shares.
By signing the notice, Hume has certified that he is not aware of any material adverse information regarding TD SYNNEX's current and prospective operations that has not been publicly disclosed.
TD SYNNEX Corporation insider Dennis Polk, who serves as both Officer and Director, has filed Form 144 indicating intent to sell 14,250 shares of common stock with an aggregate market value of $1,943,073. The sale is planned for June 27, 2025, through Morgan Stanley Smith Barney LLC on the NYSE.
The shares were acquired through a stock option exercise on June 27, 2025, with cash payment. The filing reveals Polk's recent trading history through the Polk Family Trust:
- June 4, 2025: Sold 3,000 shares for $368,814
- May 5, 2025: Sold 3,000 shares for $345,209
- April 9, 2025: Sold 3,000 shares for $315,000
The company has approximately 83.9 million shares outstanding. Polk has certified no knowledge of material adverse information about TD SYNNEX's operations that hasn't been publicly disclosed.